500 related articles for article (PubMed ID: 18324621)
1. Should trichrome stain be used on all post-liver transplant biopsies with hepatitis C virus infection to estimate the fibrosis score?
Tretheway D; Jain A; LaPoint R; Sharma R; Orloff M; Milot P; Bozorgzadeh A; Ryan C
Liver Transpl; 2008 May; 14(5):695-700. PubMed ID: 18324621
[TBL] [Abstract][Full Text] [Related]
2. Image analysis of liver collagen using sirius red is more accurate and correlates better with serum fibrosis markers than trichrome.
Huang Y; de Boer WB; Adams LA; MacQuillan G; Rossi E; Rigby P; Raftopoulos SC; Bulsara M; Jeffrey GP
Liver Int; 2013 Sep; 33(8):1249-56. PubMed ID: 23617278
[TBL] [Abstract][Full Text] [Related]
3. Killer cell immunoglobulin-like receptor genotype and killer cell immunoglobulin-like receptor-human leukocyte antigen C ligand compatibility affect the severity of hepatitis C virus recurrence after liver transplantation.
de Arias AE; Haworth SE; Belli LS; Burra P; Pinzello G; Vangeli M; Minola E; Guido M; Boccagni P; De Feo TM; Torelli R; Cardillo M; Scalamogna M; Poli F
Liver Transpl; 2009 Apr; 15(4):390-9. PubMed ID: 19326408
[TBL] [Abstract][Full Text] [Related]
4. Transient elastography predicts fibrosis progression in patients with recurrent hepatitis C after liver transplantation.
Rigamonti C; Donato MF; Fraquelli M; Agnelli F; Ronchi G; Casazza G; Rossi G; Colombo M
Gut; 2008 Jun; 57(6):821-7. PubMed ID: 18218676
[TBL] [Abstract][Full Text] [Related]
5. Diabetes and hepatic oxidative damage are associated with hepatitis C progression after liver transplantation.
Cotler SJ; Kallwitz E; TenCate V; Bhushan A; Berkes J; Benedetti E; Layden-Almer J; Layden TJ; Valyi-Nagy T; Guzman G
Transplantation; 2007 Sep; 84(5):587-91. PubMed ID: 17876270
[TBL] [Abstract][Full Text] [Related]
6. Advances in digital quantification technique enhance discrimination between mild and advanced liver fibrosis in chronic hepatitis C.
Lazzarini AL; Levine RA; Ploutz-Snyder RJ; Sanderson SO
Liver Int; 2005 Dec; 25(6):1142-9. PubMed ID: 16343064
[TBL] [Abstract][Full Text] [Related]
7. The difference in the fibrosis progression of recurrent hepatitis C after live donor liver transplantation versus deceased donor liver transplantation is attributable to the difference in donor age.
Selzner N; Girgrah N; Lilly L; Guindi M; Selzner M; Therapondos G; Adeyi O; McGilvray I; Cattral M; Greig PD; Grant D; Levy G; Renner EL
Liver Transpl; 2008 Dec; 14(12):1778-86. PubMed ID: 19025914
[TBL] [Abstract][Full Text] [Related]
8. Role of AST to platelet ratio index in the detection of liver fibrosis in patients with recurrent hepatitis C after liver transplantation.
Toniutto P; Fabris C; Bitetto D; Falleti E; Avellini C; Rossi E; Smirne C; Minisini R; Pirisi M
J Gastroenterol Hepatol; 2007 Nov; 22(11):1904-8. PubMed ID: 17914968
[TBL] [Abstract][Full Text] [Related]
9. Natural history of hepatic fibrosis progression in chronic hepatitis C virus infection in India.
Hissar SS; Kumar M; Tyagi P; Goyal A; Suneetha PV; Agarwal S; Rastogi A; Sakhuja P; Sarin SK
J Gastroenterol Hepatol; 2009 Apr; 24(4):581-7. PubMed ID: 19032460
[TBL] [Abstract][Full Text] [Related]
10. Increased T-cell sinusoidal lymphocytosis in liver biopsies in patients with chronic hepatitis C and mixed cryoglobulinemia.
Carmack S; Taddei T; Robert ME; Mistry P; Jain D
Am J Gastroenterol; 2008 Mar; 103(3):705-11. PubMed ID: 17970837
[TBL] [Abstract][Full Text] [Related]
11. Prediction of significant fibrosis in hepatitis C virus infected liver transplant recipients by artificial neural network analysis of clinical factors.
Piscaglia F; Cucchetti A; Benlloch S; Vivarelli M; Berenguer J; Bolondi L; Pinna AD; Berenguer M
Eur J Gastroenterol Hepatol; 2006 Dec; 18(12):1255-61. PubMed ID: 17099373
[TBL] [Abstract][Full Text] [Related]
12. Transient elastography for diagnosis of advanced fibrosis and portal hypertension in patients with hepatitis C recurrence after liver transplantation.
Carrión JA; Navasa M; Bosch J; Bruguera M; Gilabert R; Forns X
Liver Transpl; 2006 Dec; 12(12):1791-8. PubMed ID: 16823833
[TBL] [Abstract][Full Text] [Related]
13. The natural history of hepatitis C cirrhosis after liver transplantation.
Firpi RJ; Clark V; Soldevila-Pico C; Morelli G; Cabrera R; Levy C; Machicao VI; Chaoru C; Nelson DR
Liver Transpl; 2009 Sep; 15(9):1063-71. PubMed ID: 19718647
[TBL] [Abstract][Full Text] [Related]
14. Hyaluronic acid, transforming growth factor-beta1 and hepatic fibrosis in patients with chronic hepatitis C virus and human immunodeficiency virus co-infection.
Sanvisens A; Serra I; Tural C; Tor J; Ojanguren I; Barluenga E; Rey-Joly C; Clotet B; Muga R
J Viral Hepat; 2009 Jul; 16(7):513-8. PubMed ID: 19200132
[TBL] [Abstract][Full Text] [Related]
15. The impact of hepatic steatosis on the natural history of chronic hepatitis C infection.
Cross TJ; Quaglia A; Hughes S; Joshi D; Harrison PM
J Viral Hepat; 2009 Jul; 16(7):492-9. PubMed ID: 19200134
[TBL] [Abstract][Full Text] [Related]
16. A multivariable model of clinical variables predicts advanced fibrosis in chronic hepatitis C.
Alsatie M; Kwo PY; Gingerich JR; Qi R; Eckert G; Cummings OW; Imperiale TF
J Clin Gastroenterol; 2007 Apr; 41(4):416-21. PubMed ID: 17413613
[TBL] [Abstract][Full Text] [Related]
17. 13C-methacetin-breath test compared to also noninvasive biochemical blood tests in predicting hepatic fibrosis and cirrhosis in chronic hepatitis C.
Dinesen L; Caspary WF; Chapman RW; Dietrich CF; Sarrazin C; Braden B
Dig Liver Dis; 2008 Sep; 40(9):743-8. PubMed ID: 18339592
[TBL] [Abstract][Full Text] [Related]
18. Progression of fibrosis in chronic hepatitis C.
Ghany MG; Kleiner DE; Alter H; Doo E; Khokar F; Promrat K; Herion D; Park Y; Liang TJ; Hoofnagle JH
Gastroenterology; 2003 Jan; 124(1):97-104. PubMed ID: 12512034
[TBL] [Abstract][Full Text] [Related]
19. Liver collagen proportionate area predicts decompensation in patients with recurrent hepatitis C virus cirrhosis after liver transplantation.
Calvaruso V; Dhillon AP; Tsochatzis E; Manousou P; Grillo F; Germani G; Patch D; O'Beirne J; Burroughs AK
J Gastroenterol Hepatol; 2012 Jul; 27(7):1227-32. PubMed ID: 22432427
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis C virus therapy in liver transplant recipients: response predictors, effect on fibrosis progression, and importance of the initial stage of fibrosis.
Roche B; Sebagh M; Canfora ML; Antonini T; Roque-Afonso AM; Delvart V; Saliba F; Duclos-Vallee JC; Castaing D; Samuel D
Liver Transpl; 2008 Dec; 14(12):1766-77. PubMed ID: 19025933
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
